Rhinebeck Bancorp, Inc. Reports Results for the Quarter Ended September 30, 2026

Rhinebeck Bancorp reported third-quarter 2026 net income of $3.2 million, up 17.0% year over year, and net interest income rose 8.1% to $13.0 million. The July second-step conversion and stock offering raised $88.8 million gross, lifting stockholders’ equity to $220.8 million; deposits increased $147.0 million, or 13.4%, from year-end 2025. Credit metrics improved, with quarterly net charge-offs falling to $211,000 from $963,000, while net interest margin declined 14 basis points to 3.79% and non-performing assets rose $600,000 to $4.3 million.

Analysis

Core read: The headline earnings acceleration overstates the improvement in underlying earnings power. Roughly half of the year-over-year increase in pretax income came from a life-insurance gain, while recurring growth relied on balance-sheet expansion: quarterly NIM fell 14 bp and the average loan book contracted. The capital raise has created a deployment problem, not yet a return-on-capital story: excess funds are sitting in lower-yielding cash and securities, pulling down margins and ROE. The key valuation question is whether management can convert that liquidity into relationship loans without buying growth through higher funding costs or weaker underwriting.

Competitive and risk dynamics: Reducing indirect auto exposure may lower volatility, but it also removes a lending channel while the commercial franchise is still being built; larger regional and community banks may have an advantage in winning established commercial relationships. Uninsured deposits near 30% leave some sensitivity to confidence shocks, even with ample liquidity and reduced FHLB borrowing. A further rates-driven decline in AFS values could also offset part of the visible capital cushion. Credit is mixed rather than unambiguously improving: past dues and charge-offs eased, but nonperforming assets rose and reserve coverage of nonperforming loans declined.

Horizon/contrarian view: Near term, a positive reaction to EPS growth could fade as investors distinguish recurring earnings from the insurance gain and capital dilution. Over 1–3 quarters, watch loan growth, deposit pricing, and expense control as the decisive tests. Consensus may focus on strong capital as optionality; until deployment earns an adequate spread, it is also a drag on ROE. No valuation or price data are provided to establish an attractive entry or downside level.

Key Decisions for Investors

• Do not chase the earnings headline in RBKB; treat the quarter as modestly positive operationally but not proof that the post-conversion capital is earning its cost.
• Set a 1–3 quarter watch alert for commercial loan growth alongside NIM stabilization and deposit-cost trends. Reassess positively if loan deployment lifts recurring earnings without renewed credit deterioration; thesis weakens if excess liquidity persists and NIM continues to contract.
• Track the next credit disclosures for nonperforming assets, commercial real estate migration, and allowance coverage. A renewed rise in delinquencies or charge-offs would challenge the benign read-through from lower quarterly losses.
• No outright long/short recommendation without RBKB’s current price, valuation, and liquidity data. Falsifiers for a constructive view include sustained margin compression, accelerating operating costs, or credit deterioration that absorbs the capital buffer.